Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Êîñìåòîëîãèÿ-äåðìàòîëîãèÿ > Àëîïåöèÿ (îáëûñåíèå)

Çàêðûòàÿ òåìà
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 20.06.2020, 11:04
Nastyazelim Nastyazelim âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 20.06.2020
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 4
Nastyazelim *
Thumbs down ÆÄÀ è âûïàäåíèå âîëîñ òàê æå ùèòîäêà ïîä?

Çäðàâñòâóéòå è çàðàíåå ñïàñèáî çà ïîìîùü!
Î÷åíü ñèëüíî âûïàäàþò âîëîñû ñ íà÷àëà âåñíû
Òàê æå áûëè ãîëîâîêðóæåíèÿ ïîñëå âñòàâàíèÿ ñ êðîâàòè - áóêâàëüíî ïîñòîÿííî! 1 ðàç óïàëà â îáìîðîê + áûëè íàðóøåíèÿ ñíà è ñóõîñòü êîæè

Òàêæå ïðèìåðíî â ìàðòå áðîñèëà ïèòü ïðîòèâîçà÷àòî÷íûå äæåñ, íî èñïóãàâøèñü âûïàäåíèÿ âîëîñ âîçîáíîâèëà ïðèåì ÷åðåç ìåñÿö! (Íà äàííûé ìîìåíò ïîñëå ïåðåðûâà ïðîïèëà 2 ìåñÿöà) + äî ýòîãî ÿ äæåññ ïðåêðàùàëà íî íèêàêîãî âûïàäåíèÿ ðàíüøå íà ýòîì ôîíå íå áûëî

Ìåñÿö íàçàä îáíàðóæèëàñü æåëåçîäåôèöèòíàÿ àíåìèÿ - ãåìîãëîáèí 117, ôåððèòèí 8,7
Òàêæå ñìóòèëè àíàëèçû òòã 1,570ìÌå/ë; ò4ñâîáîäíûé 7,87 ïìîëü/ë

Íà÷àëà ïðèíèìàòü ñîðáèôåð 1óòðîì íàòîùàê+ 1 íà íî÷ü íà ãîëîäí æåëóäîê
Íà äàííûé ìîìåíò ïðèíèìàþ 3 íåäåëè è ðåçóëüòàòà ïîêà íå âèæó,÷åðåç íåäåëþ èäó äåëàòü êîíòðîëüíûé àíàëèç êðîâè - äîñòàòî÷íî ëè áóäåò ñäàòü îàê ÷òîá ïðîñëåäèòü äèíàìèêó ïî ãåìîãëîáèíó? Èëè äîïîëíèòåëüíî ñäàòü ôåððèòèí?
Òàê æå ß ÏÎÍÈÌÀÞ ×ÒÎ ËÅ×ÅÍÈÅ ÇÀÉÌÅÒ ÎÊÎËÎ ÏÎËÓÃÎÄÀ, íî ïîÿâèëàñü âîçìîæíîñòü ïðîêàïàòü æåëåçî êàïåëüíèöàìè - ýòî ïîìîæåò ìíå óñêîðèòü ðåçóëüòàò? Ò.å. ÿ õîòåëà áû ñîêðàòèòü âûïàäåíèå êàê ìîæíî ðàíüøå.
Íóæíî ëè ìíå êîððåêòèðîâàòü ò4ñâîáîäíûé ïðè íîðìàëüíîì òòã? È ìîæåò ëè ò4ñâîáîäíûé áûòü ïîíèæåííûì íà ôîíå æåëåçîäåôèöèòà?

Âûïàäåíèå íà÷àëîñü ðåçêî è â ïîñëåäíåå âðåìÿ òîëüêî óñèëèâàåòñÿ, íàøëà òàê æå îàê çà ôåâðàëü òàì ãåìîãëîáèí áûë 134 ÍÀ ÒÎÒ ÌÎÌÅÍÒ ßÂÍÛÕ ÏÐÎÁËÅÌ Ñ ÂÎËÎÑÀÌÈ ÍÅ ÁÛËÎ

Çàìåòèëà ÷òî íà ìåñòå âûïàâøèõ âîëîñ ïóñòî, íîâûå âîëîñû íå ðàñòóò - ýòî íîðìàëüíàÿ êàðòèíà ïðè æåëåçîäåôèöèòå?
Ìîæíî ëè ïðèíèìàòü ïî 1ò öèíêòåðàëà áåç àíàëèçà íà öèíê?
  #2  
Ñòàðûé 20.06.2020, 21:41
Hologram Hologram âíå ôîðóìà
ÂÐÀ×
 
Ðåãèñòðàöèÿ: 09.08.2016
Ãîðîä: Ðîññèÿ
Ñîîáùåíèé: 729
Ïîáëàãîäàðèëè 306 ðàç(à) çà 301 ñîîáùåíèé
Hologram ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHologram ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHologram ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHologram ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHologram ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHologram ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñ òàêèìè ïðîáëåìàìè âîëîñ íåîáõîäèìî îáðàòèòüñÿ òðèõîëîãó íà î÷íóþ êîíñóëüòàöèþ, íà êîòîðîé ñ ïîìîùüþ òðèõîñêîïèè ïî õàðàêòåðíûì ïðèçíàêàì âðà÷ óñòàíîâèò òèï âûïàäåíèÿ âûïàäåíèÿ - äèôôóçíàÿ òåëîãåíîâàÿ, äèôôóçíàÿ ãí¸çäíàÿ àëîïåöèÿ èëè ÷òî-íèáóäü äðóãîå.
Îò äèàãíîçà çàâèñèò ñõåìà ëå÷åíèÿ: ïðåïàðàòû, ïðîäîëæèòåëüíîñòü, ïðîãíîç.
  #3  
Ñòàðûé 21.06.2020, 01:09
Nastyazelim Nastyazelim âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 20.06.2020
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 4
Nastyazelim *
Ñïàñèáî çà îòâåò! Ïðàâäà ÿ çàäàëà êîíêðåòíûé âîïðîñ î æåëåçîäåôèöèòå 🤔 ìîæåò ïîìîæåòå â ãåìîòîëîãèþ ïåðåíåñòè èëè ïîäñêàæèòå êàê?
Ó òðèõîëîãà áûëà, ôòã äåëàòü íå ñòàë, ñìîòðåë â òðèõîñêîï - ïðèçíàêè àãà åñòü êîíå÷íî, íî ñêàçàë ÷òî âûïàäåíèå ðåàêòèâíîå è íóæíî èñêàòü òðèããåð è óñòðàíÿòü.. ïîýòîìó óæå è ïîøëà ñäàâàòü àíàëèçû è ïîøëà ê ýíäîêðèíîëîãó 🤷🏽♀
  #4  
Ñòàðûé 21.06.2020, 03:38
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,391
Ïîáëàãîäàðèëè 33,235 ðàç(à) çà 31,584 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
äëÿ êîððåêöèè æäà - áèñãëèöèíàò æåëåçà 25 ìã â òå÷åíèå 4-6 ìåñ.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
  #5  
Ñòàðûé 21.06.2020, 12:54
Nastyazelim Nastyazelim âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 20.06.2020
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 4
Nastyazelim *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
äëÿ êîððåêöèè æäà - áèñãëèöèíàò æåëåçà 25 ìã â òå÷åíèå 4-6 ìåñ.
Ñïàñèáî! Ìíå èñêðåííå õî÷åòñÿ âåðèòü ÷òî Âû îïå÷àòàëèñü)
Âû êàê âðà÷ äîëæíû çíàòü ÷òî çîëîòîé ñòàíäàðò ëå÷åíèÿ æäà ýòî ïðåïàðàòû äâóõâàëåíòíîãî æåëåçà.
Âû ñåðüåçíî êîìó-òî ëå÷èòå àíåìèþ áàäàìè äà è åùå â òàêîé ñìåøíîé äîçèðîâêå?! Âû òàê âåêàìè ëå÷èòü áóäåòå... æàëü Âàøèõ ïàöèåíòîâ 🤦🏽♀
  #6  
Ñòàðûé 21.06.2020, 13:45
BIS BIS âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 04.12.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 3,059
Ñêàçàë(à) ñïàñèáî: 4
Ïîáëàãîäàðèëè 1,158 ðàç(à) çà 1,139 ñîîáùåíèé
BIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íåò, íå îïå÷àòàëñÿ âðà÷-ãåìÀòîëîã.
Ïîòðóäèòåñü ïî÷èòàòü àðõèâû. È Âû ïîéì¸òå êàêóþ ãëóïîñòü ñìîðîçèëè.
Íà ìåñòå êîëëåã- ÿ áû ñ Âàìè ðàçãîâîð çàêîí÷èëà.
  #7  
Ñòàðûé 21.06.2020, 14:16
Nastyazelim Nastyazelim âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 20.06.2020
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 4
Nastyazelim *
Âû óìååòå ÷èòàòü? ß ïðèíèìàþ ñåé÷àñ 200ìã æåëåçà, âðàæ ìíå ïðåäëîæèë 25?!
Òóò ÿ äèàëîã çàêàí÷èâàþ
Íàïèñàëà ýòî ñîîáùåíèå ëèøü ïîòîìó ÷òî âîçìîæíî êòî-òî èç òåõ, êòî çàéäåò â ýòó âåòêó ïîéìåò ÷òî íå âñåãäà òóò õîðîøèå ñîâåòû äàþò.
Ïî÷èòàéòå ÔÅÄÅÐÀËÜÍÛÅ ÊËÈÍÈ×ÅÑÊÈÅ ÐÅÊÎÌÅÍÄÀÖÈÈ ÏÎ ÄÈÀÃÍÎÑÒÈÊÅ È ËÅ×ÅÍÈÞ ÆÅËÅÇÎÄÅÔÈÖÈÒÍÎÉ ÀÍÅÌÈÈ ÌÈÍÇÄÐÀÂÀ ÐÎÑÑÈÈ
  #8  
Ñòàðûé 21.06.2020, 14:25
BIS BIS âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 04.12.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 3,059
Ñêàçàë(à) ñïàñèáî: 4
Ïîáëàãîäàðèëè 1,158 ðàç(à) çà 1,139 ñîîáùåíèé
BIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBIS ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïîñëåäíåå. Íèêîãäà Âû íå íàéä¸òå îáùåãî ÿçûêà ñ î÷íûìè âðà÷àìè.
Âû ïîíèìàåòå ôàðìàêîêèíåòèêó è ôàðìàêîäèíàìèêó ñóëüôàòà è áèñãëèöèíàòà?..
Ïðîñòî ïîâåðüòå, ãåìàòîëîã èõ ïîíèìàåò ëó÷øå ìåíÿ è Âàñ è çíàåò, Î ×ÅÌ îí ãîâîðèò.
Íå ñòÎèò íàñ çäåñü ïóãàòü ÔÅÄÅÐÀËÜÍÛÌÈ ÊËÈÍÈ×ÅÑÊÈÌÈ ÐÅÊÎÌÅÍÄÀÖÈßÌÈ. Èõ ìíîãèå ïèñàëè))))
Åù¸ ðàç, ëè÷íî ÂÀÌ ïîïûòàëèñü ïîìî÷ü.
ß áû ðàçãîâàðèâàòü ñ Âàìè íå ñòàëà ïîñëå ñòàðòòîïèêà.
Âñåãî äîáðîãî!

Êîììåíòàðèè ê ñîîáùåíèþ:
Dr.Vad îäîáðèë(à):
  #9  
Ñòàðûé 21.06.2020, 20:14
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,391
Ïîáëàãîäàðèëè 33,235 ðàç(à) çà 31,584 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äà, ñîãëàñåí, â ÐÔ ìíîãèå ðåêîìåíäàöèè îòñòàëè îò ñîâðåìåííîé ìåäèöèíû ëåò íà 10-20 â òîì ÷èñëå è ïî ëå÷åíèþ æäà, çàñòðÿìøè íàâåêè â ïðîøëîì âåêå èëè òûñÿ÷åëåòèè, äëÿ âñå îñòàëüíûõ, êòî ÷èòàåò ýòîò òîïèê, òàê êàê íàäåþñü òîïèê-ñòàðòåð ïîêèíóëà íàñ íàâñåãäà êàê îáåùàëà:

áèñãëèöèíàò â ìåíüøåé äîçå ëó÷øå ïðåäóïðåæäàë æä ó áåðåìåííûõ â òîì ÷èñëå è èç-çà ëó÷øåé ïåðåíîñèìîñòè:

effectiveness of daily supplementation of iron deficiency during pregnancy using 15 mg/day of iron from iron-bis-glycinate chelate (71 pregnant women), or 40 mg iron from ferrous sulfate (74 pregnant women) was evaluated by measuring hemoglobin, transferrin saturation and serum ferritin, at the beginning of the study (<20 weeks of pregnancy) and at 20-30 weeks and 30-40 weeks thereafter. Ingestion for 13 weeks or more was considered adequate. 73% of the Ferrochel consuming group and 35% of the ferrous sulfate consuming group were considered to have taken the treatment adequately. The decrease in levels of all the measured parameters was significantly less pronounced in the group that consumed Ferrochel in spite of the lower treatment dose. Iron depletion was found in 30.8% of the women treated with Ferrochel and in 54.5% of the women than consumed ferrous sulfate.//ALAN v.51 n.1 supl.1 Caracas mar. 2001

íàçíà÷åíèå îäèíàêîâûõ äîç ïîâûøàëî ãåìîãëîáèí ëó÷øå è ñ ìåíüùèì ÷èñëîì ïîáî÷íûõ äåéñòâèé:

The study included 187 women in the final analysis. The mean increase in HB level after 8 weeks of treatment in ferrous bis-glycinate group was 2.48 ± 0.12 g/dL versus 1.32 ± 0.18 g/dL in ferrous glycine sulfate group (p ≤ .0001). The percentage of women with HB level more than 11 g/dL after 8 weeks of treatment was 89.2% in ferrous bis-glycinate group versus 71.3% in ferrous glycine sulfate group (p < .0001). The rate of adverse effects was significantly higher in ferrous glycine sulfate group (p = .001).
---
Efficacy of ferrous bis-glycinate versus ferrous glycine sulfate in the treatment of iron deficiency anemia with pregnancy: a randomized double-blind clinical trial

Ê ñîæàëåíèþ, ýòî ïðîáëåìà ìèíçäðàâà ÐÔ, ÷òî íåêîòîðûå ëåêàðñòâà êîìïàíèÿì ïðîùå ïðîäàâàòü â âèäå ÁÀÄîâ - òî æå æåëåçà áèñãëèöèíàò ïîëó÷èë ñåðòèôèêàöèþ íà òåððèòîðèè Óêðàèíû è ïðîäàåòñÿ äëÿ äåòåé è âçðîñëûõ â àïòåêàõ.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
  #10  
Ñòàðûé 08.11.2020, 04:12
DrYPI DrYPI âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 15.03.2013
Ãîðîä: Ïðîâèíöèÿ
Ñîîáùåíèé: 23
Ñêàçàë(à) ñïàñèáî: 7
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
DrYPI *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
Äà, ñîãëàñåí, â ÐÔ ìíîãèå ðåêîìåíäàöèè îòñòàëè îò ñîâðåìåííîé ìåäèöèíû ëåò íà 10-20 â òîì ÷èñëå è ïî ëå÷åíèþ æäà, çàñòðÿìøè íàâåêè â ïðîøëîì âåêå èëè òûñÿ÷åëåòèè, äëÿ âñå îñòàëüíûõ, êòî ÷èòàåò ýòîò òîïèê, òàê êàê íàäåþñü òîïèê-ñòàðòåð ïîêèíóëà íàñ íàâñåãäà êàê îáåùàëà:

áèñãëèöèíàò â ìåíüøåé äîçå ëó÷øå ïðåäóïðåæäàë æä ó áåðåìåííûõ â òîì ÷èñëå è èç-çà ëó÷øåé ïåðåíîñèìîñòè:

effectiveness of daily supplementation of iron deficiency during pregnancy using 15 mg/day of iron from iron-bis-glycinate chelate (71 pregnant women), or 40 mg iron from ferrous sulfate (74 pregnant women) was evaluated by measuring hemoglobin, transferrin saturation and serum ferritin, at the beginning of the study (<20 weeks of pregnancy) and at 20-30 weeks and 30-40 weeks thereafter. Ingestion for 13 weeks or more was considered adequate. 73% of the Ferrochel consuming group and 35% of the ferrous sulfate consuming group were considered to have taken the treatment adequately. The decrease in levels of all the measured parameters was significantly less pronounced in the group that consumed Ferrochel in spite of the lower treatment dose. Iron depletion was found in 30.8% of the women treated with Ferrochel and in 54.5% of the women than consumed ferrous sulfate.//ALAN v.51 n.1 supl.1 Caracas mar. 2001

íàçíà÷åíèå îäèíàêîâûõ äîç ïîâûøàëî ãåìîãëîáèí ëó÷øå è ñ ìåíüùèì ÷èñëîì ïîáî÷íûõ äåéñòâèé:

The study included 187 women in the final analysis. The mean increase in HB level after 8 weeks of treatment in ferrous bis-glycinate group was 2.48 ± 0.12 g/dL versus 1.32 ± 0.18 g/dL in ferrous glycine sulfate group (p ≤ .0001). The percentage of women with HB level more than 11 g/dL after 8 weeks of treatment was 89.2% in ferrous bis-glycinate group versus 71.3% in ferrous glycine sulfate group (p < .0001). The rate of adverse effects was significantly higher in ferrous glycine sulfate group (p = .001).
---
Efficacy of ferrous bis-glycinate versus ferrous glycine sulfate in the treatment of iron deficiency anemia with pregnancy: a randomized double-blind clinical trial

Ê ñîæàëåíèþ, ýòî ïðîáëåìà ìèíçäðàâà ÐÔ, ÷òî íåêîòîðûå ëåêàðñòâà êîìïàíèÿì ïðîùå ïðîäàâàòü â âèäå ÁÀÄîâ - òî æå æåëåçà áèñãëèöèíàò ïîëó÷èë ñåðòèôèêàöèþ íà òåððèòîðèè Óêðàèíû è ïðîäàåòñÿ äëÿ äåòåé è âçðîñëûõ â àïòåêàõ.
.
ãëóïîñòü ïàöèåíòîâ,åùå è âûñêàçàííàÿ â ôîðìå àêñèîìû èíîãäà ñìåøèò,èíîãäà ðàññòðàèâàåò).Äàâíî íå áûëà íà ôîðóìå.Åùå ðàç ïîáëàãîäàðþ Âàñ,êîëëåãà,ÿ êàê òðèõîëîã,ìíîãîå ïî÷åðïíóëà â ñâîå âðåìÿ ó Âàñ ïî êîððåêöèè ËÄÆ ó ñâîèõ ïàöèåíòîâ))
  #11  
Ñòàðûé 08.11.2020, 09:01
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,273
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,622 ðàç(à) çà 32,696 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
À òåìó ïîðà çàêðûòü
__________________
Ã.À. Ìåëüíè÷åíêî
Çàêðûòàÿ òåìà



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 10:49.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.